Official conference page for 2026 Best of Hematology, Austin.

About 2026 Best of Hematology, Austin

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

74+

Faculty and committee

Conference program and agenda

Our Agenda

Saturday, May 16th, 2026

All timings are in Central Standard Time (CST, GMT-06:00) time.

07:00 AM - 07:55 AMRegistration, Breakfast, & Exhibits (Continental 3)
07:55 AM - 08:00 AMWelcome (Continental 1&2)
08:00 AM - 08:15 AMBinaytara's Efforts in Improving Cancer Care Disparities (Continental 1&2)
08:15 AM - 09:45 AMSession 1: Updates in Leukemia / MDS (Continental 1&2)

Session Chair: Hycienth Ahaneku Ahaneku, MD

08:15 AM - 08:45 AM

Updates of MDS Boone Goodgame, MD

08:45 AM - 09:00 AM

Treatment of AML Tapan Kadia, MD

09:00 AM - 09:15 AM

MPN/CML Disorders Stephen Anthony Strickland, MD

09:15 AM - 09:45 AM

Case-Based Panel Discussion (Case Presenter: Kenton Wong)

Moderators:

Hycienth Ahaneku Ahaneku, MD

Panelists:

Kenton Wong, MD; Boone Goodgame, MD; Tapan Kadia, MD; Stephen Anthony Strickland, MD

09:45 AM - 11:15 AMSession 2: Multiple Myeloma (Continental 1&2)

Session Chair: Athira Unnikrishnan, MD

09:45 AM - 10:15 AM

Upfront Treatment of Myeloma William Matsui, MD

10:15 AM - 10:30 AM

Bi-specifics Aravind Ramakrishnan, MD

10:30 AM - 10:45 AM

CAR-T Therapy for Myeloma Shahbaz Malik, MD

10:45 AM - 11:15 AM

Panel Discussion

Moderators:

Athira Unnikrishnan, MD

Panelists:

William Matsui, MD; Aravind Ramakrishnan, MD; Shahbaz Malik, MD

11:15 AM - 12:15 PMLunch & Exhibits (Continental 3) - Product Theater sponsored by JNJ (Non-CME Accredited): Making the Case for Early Use of CAR-T Therapy in Multiple Myeloma - Uttam Rao, MD (The Gallery)
12:15 PM - 12:45 PMSession 3: Emerging Role of Immunotherapies in Multiple Myeloma (Continental 1&2)

Session Chair: Wilson Gonsalves, MD

12:45 PM - 02:30 PMSession 4: High grade Lymphoma (Continental 1&2)

Session Chair: Timothy Fenske, MD

12:45 PM - 01:15 PM

Upfront Treatment of DLBCL Athira Unnikrishnan, MD

01:15 PM - 01:30 PM

Treatment of Relapsed Aggressive Lymphoma Timothy Fenske, MD

01:30 PM - 01:45 PM

CAR-T Therapy for Relapsed Aggressive Lymphoma Paul Shaughnessy, MD

01:45 PM - 02:00 PM

Treatment of Aggressive T-Cell Lymphomas Ranjit Nair, MD

02:00 PM - 02:30 PM

Panel Discussion

Moderators:

Timothy Fenske, MD

Panelists:

Athira Unnikrishnan, MD; Timothy Fenske, MD; Paul Shaughnessy, MD; Ranjit Nair, MD

02:30 PM - 03:15 PMBreak & Exhibits (Continental 3) - Product Theater sponsored by Bristol Myers Squibb (Non-CME Accredited): Advancing CAR T Therapy: GPRC5D as the Next Frontier in Relapsed/Refractory Multiple Myeloma - Ivan Reveles, PharmD, MS, BCOP (The Gallery)
03:15 PM - 04:45 PMSession 5: Low grade Lymphoma / CLL (Continental 1&2)

Session Chair: Jane Chawla, MD

03:15 PM - 03:45 PM

Updates in CLL Jason Melear, MD

03:45 PM - 04:00 PM

Updates in Low Grade Lymphoma Praveen Ramakrishnan Geethakumari, MD, MBA

04:00 PM - 04:15 PM

Updates in Mantle Cell Lymphoma Preetesh Jain, MD

04:15 PM - 04:45 PM

Panel Discussion

Moderators:

Jane Chawla, MD

Panelists:

Jason Melear, MD; Praveen Ramakrishnan Geethakumari, MD, MBA; Preetesh Jain, MD

04:45 PM - 04:45 PMAdjourn

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship